Belvedere Trading’s BioVie BIVI Stock Holding History

Belvedere Trading’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-237	Closed	-$80.8K	–	816
2023 Q3	$80.8K	Buy	237 +236	+23,600%	+$92.2K	﹤0.01%	368
2023 Q2	$431	Sell	1 -37	-97%	-$24.9K	﹤0.01%	822
2023 Q1	$30.7K	Buy	+38	New	+$25.2K	﹤0.01%	657

Other funds holding BIVI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Belvedere Trading's BIVI Position: Q1 2025 in Review

Belvedere Trading sold out of BioVie (BIVI) in Q1 2025, closing a stake of 962 shares — an estimated $19.2K sold.

Belvedere Trading first reported a position in BIVI in Q1 2023 and held it in 4 quarters. The position peaked at $42.5K in Q2 2023. 37 funds tracked by Wall St. Rank hold BIVI as of Q1 2025.

Belvedere Trading reported no remaining BioVie position as of Q1 2025 after selling out during the quarter.
Belvedere Trading sold 962 BioVie shares in Q1 2025, an estimated $19.2K.
Belvedere Trading first reported a position in BioVie in Q1 2023 and held it in 4 quarters.
Belvedere Trading's BioVie position peaked at $42.5K in Q2 2023.
37 funds tracked by Wall St. Rank held BioVie as of Q1 2025.

Based on Belvedere Trading's 13F filing for Q1 2025, filed 9 May 2025.